Publications  
  
Please Choose a Publications Category by clicking one of the following links:
Breast Cancer
Colon Cancer
Hematological Disorders
Lung Cancer
Ovarian Cancer
Prostate Cancer
Cardiovascular Disease
Diagnostic Development/Clinical Proteomics
Prostate Cancer
No.   Title   Author
608     Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer Asian J Androl. 2006 Jan;8(1):45-51 [read]     Pan YZ, Xiao XY, Zhao D, Zhang L, Ji GY, Li Y, Yang BX, He DC, Zhao XJ.
445     Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res. 2005 Feb 1;11(3):1073-85 [read]     Gunjan Malik, Michael D Ward, Saurabh K Gupta, Michael W Trosset, William E Grizzle, Bao-Ling Adam, Jose I Diaz, O. John Semmes
357     Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection Analytical Biochemistry 338 (2005) 26–31 [read]     Jérôme Solassol, Philippe Marin, Edith Demettre, Philippe Rouanet, Joël Bockaert, Thierry Maudelonde, Alain Mangé
337     Proteomic patterns: their potential for disease diagnosis Mol Cell Endocrinol. 2005 Jan 31;230(1-2):95-106 [read]     Xiao Z, Prieto D, Conrads TP, Veenstra TD, Issaq HJ
332     Analysis of prostate cancer by proteomics using tissue specimens J Urol. 2005 Jan;173(1):73-8 [read]     A.Y. Liu, H. Zhang, C.M. Sorensen, D. L. Diamond
326     Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility Clin Chem. 2005 Jan;51(1):102-12. [read]     O. John Semmes, Ziding Feng, Bao-Ling Adam
307     Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF Prostate. 2004 Sep 1;60(4):325-31 [read]     Gretzer MB, Chan DW, van Rootselaar CL, Rosenzweig JM, Dalry
283     Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer Dis Markers. 2003-2004;19(4-5):185-95 [read]     Grizzle WE, Adam BL, Bigbee WL, Conrads TP, Carroll C, Feng
281     Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis Urologic Oncology: Seminars and Original Investigations 22 (2004) 329–336 [read]     Diaz JI, Cazares LH, Corica A, Semmes OJ
249     Detection of Prostate Cancer using Serum Proteomics Pattern in a Histologically confirmed Population Journal of Urology, 171, 1782-1787, (2004 [read]     Li, J., White, N., Zhang, Z., Rosenzweig, J., Mangold, L.A.,
235     Probabilistic Disease Classification of Expression-Dependent Proteomic Data from Mass Spectrometry of Human Serum Journal of Computational Biology, 10, 925-946, (2003) [read]     Lilien, R.H., Farid, H., Donald, B.R.
185     Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI) Reviews in Urology, 5, 81-89, (2003 [read]     Gretzer, M.B., Partin, A.W., Chan, D.W., Veltri, R.W.
184     Putative protein markers in the sera of men with prostatic neoplasms BJU International, 92, 223-225, (2003) [read]     Lehrer S, Roboz J, Ding H, Zhao S, Diamond EJ, Holland JF, Stone NN, Droller MJ, Stock RG.
137     Diagnostic Potential of Serum Proteomic Patterns in Prostate Cancer Journal of Urology, 170, 442-446, (2003) [read]     Bañez, L.L., Prasanna, P., Sun. L., Ali, A., Zou, Z., Adam
121     Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients Clinical Chemistry, 48, 1835-1843, (2002 [read]     Qu Y., Adam B.L., Yasui Y., Ward M.D., Cazares L.H., Schellh
101     Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men Cancer Research 62, 3609-3614, (2002) [read]     Adam, B., Qu, Y., Davis, J.W., Ward, M.D., Clements, M.A., C
51     Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease Cancer Research, 61, 6029-6033, (2001) [read]     Xiao, Z., Adam., B.L., Cazares, L.H., Clements, M.A., Davis,
 Copyright 2010 Vermillion